KR20120031800A - An antioxidant, antidiabetic and antiaging composition containing mulberry fruit seed extracts - Google Patents
An antioxidant, antidiabetic and antiaging composition containing mulberry fruit seed extracts Download PDFInfo
- Publication number
- KR20120031800A KR20120031800A KR1020100093405A KR20100093405A KR20120031800A KR 20120031800 A KR20120031800 A KR 20120031800A KR 1020100093405 A KR1020100093405 A KR 1020100093405A KR 20100093405 A KR20100093405 A KR 20100093405A KR 20120031800 A KR20120031800 A KR 20120031800A
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- seeds
- seed
- mulberry
- fruit
- Prior art date
Links
- 240000000249 Morus alba Species 0.000 title claims abstract description 87
- 235000008708 Morus alba Nutrition 0.000 title claims abstract description 87
- 239000000284 extract Substances 0.000 title claims abstract description 49
- 239000000203 mixture Substances 0.000 title claims abstract description 35
- 230000003712 anti-aging effect Effects 0.000 title claims abstract description 21
- 235000013399 edible fruits Nutrition 0.000 title claims description 94
- 239000003963 antioxidant agent Substances 0.000 title claims description 24
- 230000003078 antioxidant effect Effects 0.000 title claims description 22
- 230000003178 anti-diabetic effect Effects 0.000 title description 15
- 239000003472 antidiabetic agent Substances 0.000 title description 12
- 239000000401 methanolic extract Substances 0.000 claims abstract description 35
- 239000004480 active ingredient Substances 0.000 claims abstract description 15
- 206010012601 diabetes mellitus Diseases 0.000 claims abstract description 12
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 10
- 235000013402 health food Nutrition 0.000 claims abstract description 4
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 25
- 239000002537 cosmetic Substances 0.000 claims description 11
- 235000013376 functional food Nutrition 0.000 claims description 6
- 230000036541 health Effects 0.000 claims description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract description 18
- 230000003064 anti-oxidating effect Effects 0.000 abstract 1
- 241000218211 Maclura Species 0.000 description 43
- 239000003921 oil Substances 0.000 description 28
- 235000019198 oils Nutrition 0.000 description 28
- 235000013824 polyphenols Nutrition 0.000 description 23
- 235000006708 antioxidants Nutrition 0.000 description 21
- 150000008442 polyphenolic compounds Chemical class 0.000 description 18
- 229930003935 flavonoid Natural products 0.000 description 16
- 150000002215 flavonoids Chemical class 0.000 description 16
- 235000017173 flavonoids Nutrition 0.000 description 16
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 15
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 14
- 235000014113 dietary fatty acids Nutrition 0.000 description 14
- 239000000194 fatty acid Substances 0.000 description 14
- 229930195729 fatty acid Natural products 0.000 description 14
- 150000004665 fatty acids Chemical class 0.000 description 14
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 11
- 230000004071 biological effect Effects 0.000 description 11
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 11
- 229930003799 tocopherol Natural products 0.000 description 11
- 239000011732 tocopherol Substances 0.000 description 11
- 235000013305 food Nutrition 0.000 description 10
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 10
- 238000004458 analytical method Methods 0.000 description 9
- -1 pH adjusters Substances 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 235000010384 tocopherol Nutrition 0.000 description 9
- 229960001295 tocopherol Drugs 0.000 description 9
- WGVKWNUPNGFDFJ-DQCZWYHMSA-N beta-Tocopherol Natural products OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C WGVKWNUPNGFDFJ-DQCZWYHMSA-N 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 238000004128 high performance liquid chromatography Methods 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- 241000196324 Embryophyta Species 0.000 description 7
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 7
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 7
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 7
- 108010028144 alpha-Glucosidases Proteins 0.000 description 7
- 239000000796 flavoring agent Substances 0.000 description 7
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 7
- 235000005875 quercetin Nutrition 0.000 description 7
- 229960001285 quercetin Drugs 0.000 description 7
- 229940016667 resveratrol Drugs 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 102000003425 Tyrosinase Human genes 0.000 description 6
- 108060008724 Tyrosinase Proteins 0.000 description 6
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 6
- 229940076810 beta sitosterol Drugs 0.000 description 6
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 6
- 235000013361 beverage Nutrition 0.000 description 6
- 235000010382 gamma-tocopherol Nutrition 0.000 description 6
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000000546 pharmaceutical excipient Substances 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 6
- 229950005143 sitosterol Drugs 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 5
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 5
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 5
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 5
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 5
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 5
- 239000005642 Oleic acid Substances 0.000 description 5
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 5
- 235000021314 Palmitic acid Nutrition 0.000 description 5
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 5
- 235000021355 Stearic acid Nutrition 0.000 description 5
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 5
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 5
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 5
- 239000002585 base Substances 0.000 description 5
- 238000007796 conventional method Methods 0.000 description 5
- 235000013355 food flavoring agent Nutrition 0.000 description 5
- 238000004817 gas chromatography Methods 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 5
- 229960004488 linolenic acid Drugs 0.000 description 5
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 5
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 5
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 5
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 5
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 5
- 239000008117 stearic acid Substances 0.000 description 5
- 229960004274 stearic acid Drugs 0.000 description 5
- 229940032091 stigmasterol Drugs 0.000 description 5
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 5
- 235000016831 stigmasterol Nutrition 0.000 description 5
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 5
- 235000004835 α-tocopherol Nutrition 0.000 description 5
- 235000007680 β-tocopherol Nutrition 0.000 description 5
- 239000002478 γ-tocopherol Substances 0.000 description 5
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 description 5
- 230000002292 Radical scavenging effect Effects 0.000 description 4
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 4
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 239000006227 byproduct Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000003085 diluting agent Substances 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 238000011002 quantification Methods 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 235000021283 resveratrol Nutrition 0.000 description 4
- 150000004671 saturated fatty acids Chemical class 0.000 description 4
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 4
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 4
- 239000002076 α-tocopherol Substances 0.000 description 4
- 239000011590 β-tocopherol Substances 0.000 description 4
- GZIFEOYASATJEH-VHFRWLAGSA-N δ-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-VHFRWLAGSA-N 0.000 description 4
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 3
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 3
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 3
- 102000003886 Glycoproteins Human genes 0.000 description 3
- 108090000288 Glycoproteins Proteins 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 229940087168 alpha tocopherol Drugs 0.000 description 3
- 235000021342 arachidonic acid Nutrition 0.000 description 3
- 229940114079 arachidonic acid Drugs 0.000 description 3
- 229940066595 beta tocopherol Drugs 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000000378 dietary effect Effects 0.000 description 3
- 235000015872 dietary supplement Nutrition 0.000 description 3
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 235000004626 essential fatty acids Nutrition 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 235000015203 fruit juice Nutrition 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 230000001766 physiological effect Effects 0.000 description 3
- 229940068065 phytosterols Drugs 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 239000000829 suppository Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- 229960000984 tocofersolan Drugs 0.000 description 3
- 150000003611 tocopherol derivatives Chemical class 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 239000000080 wetting agent Substances 0.000 description 3
- BNGXYYYYKUGPPF-UHFFFAOYSA-M (3-methylphenyl)methyl-triphenylphosphanium;chloride Chemical compound [Cl-].CC1=CC=CC(C[P+](C=2C=CC=CC=2)(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 BNGXYYYYKUGPPF-UHFFFAOYSA-M 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- GZIFEOYASATJEH-UHFFFAOYSA-N D-delta tocopherol Natural products OC1=CC(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 2
- 208000005176 Hepatitis C Diseases 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
- 241000218213 Morus <angiosperm> Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 235000021319 Palmitoleic acid Nutrition 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 239000003125 aqueous solvent Substances 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 235000014121 butter Nutrition 0.000 description 2
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 239000012159 carrier gas Substances 0.000 description 2
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 235000010389 delta-tocopherol Nutrition 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- 230000003389 potentiating effect Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 235000005493 rutin Nutrition 0.000 description 2
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 2
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 2
- 229960004555 rutoside Drugs 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 235000012222 talc Nutrition 0.000 description 2
- 235000013616 tea Nutrition 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 235000019149 tocopherols Nutrition 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 description 2
- 239000002446 δ-tocopherol Substances 0.000 description 2
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- JQMFQLVAJGZSQS-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)NC1=CC2=C(NC(O2)=O)C=C1 JQMFQLVAJGZSQS-UHFFFAOYSA-N 0.000 description 1
- BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 description 1
- IFBHRQDFSNCLOZ-ZIQFBCGOSA-N 4-nitrophenyl alpha-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC1=CC=C([N+]([O-])=O)C=C1 IFBHRQDFSNCLOZ-ZIQFBCGOSA-N 0.000 description 1
- CONKBQPVFMXDOV-QHCPKHFHSA-N 6-[(5S)-5-[[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]methyl]-2-oxo-1,3-oxazolidin-3-yl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C[C@H]1CN(C(O1)=O)C1=CC2=C(NC(O2)=O)C=C1 CONKBQPVFMXDOV-QHCPKHFHSA-N 0.000 description 1
- DFGKGUXTPFWHIX-UHFFFAOYSA-N 6-[2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]acetyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)C1=CC2=C(NC(O2)=O)C=C1 DFGKGUXTPFWHIX-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 244000024469 Cucumis prophetarum Species 0.000 description 1
- 235000010071 Cucumis prophetarum Nutrition 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 239000001512 FEMA 4601 Substances 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 235000019687 Lamb Nutrition 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 206010029240 Neuritis Diseases 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 241000206607 Porphyra umbilicalis Species 0.000 description 1
- 102100038280 Prostaglandin G/H synthase 2 Human genes 0.000 description 1
- 108050003267 Prostaglandin G/H synthase 2 Proteins 0.000 description 1
- 244000184734 Pyrus japonica Species 0.000 description 1
- HELXLJCILKEWJH-SEAGSNCFSA-N Rebaudioside A Natural products O=C(O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@]1(C)[C@@H]2[C@](C)([C@H]3[C@@]4(CC(=C)[C@@](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@H](O)[C@@H](CO)O5)(C4)CC3)CC2)CCC1 HELXLJCILKEWJH-SEAGSNCFSA-N 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- MOQOOKGPCBQMCY-UHFFFAOYSA-N acetic acid;hexane Chemical compound CC(O)=O.CCCCCC MOQOOKGPCBQMCY-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 238000002792 antioxidant assay Methods 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- 235000012241 calcium silicate Nutrition 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 238000007398 colorimetric assay Methods 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- HELXLJCILKEWJH-UHFFFAOYSA-N entered according to Sigma 01432 Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O HELXLJCILKEWJH-UHFFFAOYSA-N 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 231100000304 hepatotoxicity Toxicity 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 238000000099 in vitro assay Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000000185 intracerebroventricular administration Methods 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- VMPHSYLJUKZBJJ-UHFFFAOYSA-N lauric acid triglyceride Natural products CCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC)COC(=O)CCCCCCCCCCC VMPHSYLJUKZBJJ-UHFFFAOYSA-N 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 230000007056 liver toxicity Effects 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000002831 pharmacologic agent Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 235000017807 phytochemicals Nutrition 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229930000223 plant secondary metabolite Natural products 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000019203 rebaudioside A Nutrition 0.000 description 1
- 238000000611 regression analysis Methods 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000012289 standard assay Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 150000007964 xanthones Chemical class 0.000 description 1
- 125000001020 α-tocopherol group Chemical group 0.000 description 1
- 150000003772 α-tocopherols Chemical class 0.000 description 1
- 150000003781 β-tocopherols Chemical class 0.000 description 1
- 150000003785 γ-tocopherols Chemical class 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
Abstract
Description
본 발명은 뽕나무 열매 씨앗 추출물을 함유하는 항산화, 항당뇨 및 항노화 활성 조성물에 관한 것으로, 보다 구체적으로는 뽕나무(Morus alba)(MA)와 꾸지뽕나무(Cudramia tricuspidata)(CT) 열매의 씨앗으로부터 추출한 오일 및 MeOH 추출물을 유효성분으로 함유하는 당뇨병 예방 또는 치료용 약제학적 조성물, 당뇨병 예방 또는 개선용 건강기능식품 조성물, 및 항산화 및 항노화 활성 화장료 조성물에 관한 것이다.
The present invention relates to an antioxidant, anti-diabetic and anti-aging active compositions containing mulberry fruit seed extract, more specifically, mulberry (Morus alba ) (MA) and Cudramia tricuspidata ) (CT) relates to a pharmaceutical composition for preventing or treating diabetes, a dietary supplement for preventing or improving diabetes, and an antioxidant and anti-aging active cosmetic composition comprising an oil and MeOH extract extracted from a seed of a fruit as an active ingredient. .
식물을 원료로 한 기능성 식품이 몇 가지 병리학적 질환, 예를 들어, 암, 심혈관 질환, 관절염, 백내장 및 노화의 예방에 있어 중요한 생리학적 역할을 한다고 보고된 바 있다. 특히, 과일 주스 가공 과정에서 부산물로 얻어진 식물 씨앗이 퇴행성 질환에 효과적일 수 있는 중요한 식물성 생리활성 물질(phytochemical)을 함유한 필수 지방산 및 기능성 식품의 우수한 원료가 될 수 있다고 알려져 있다. 또한 오일 추출 후 남은 씨앗 잔류물이 식이 항산화제의 유용한 원료로서 새롭게 각광받고 있다. 이러한 이유들로, 식물 씨앗을 식이 보충제 원료로서 사용하기 위해 식물 씨앗의 기능성 성분 및 생물학적 활성에 대한 연구가 필요한 실정이다.Functional foods based on plants have been reported to play an important physiological role in the prevention of several pathological diseases such as cancer, cardiovascular disease, arthritis, cataracts and aging. In particular, it is known that plant seeds obtained as by-products during fruit juice processing may be excellent raw materials for essential fatty acids and functional foods containing important phytochemicals that may be effective for degenerative diseases. Seed residues left after oil extraction are also emerging as a useful source of dietary antioxidants. For these reasons, there is a need for research on the functional components and biological activities of plant seeds in order to use them as a dietary supplement source.
대한민국 전통 의약에서는 두 가지 유형의 뽕나무, 즉 뽕나무(Morus alba)(MA)와 꾸지뽕나무(Cudramia tricuspidata)(CT)가 널리 사용되어왔다. 뽕나무(MA)의 열매인 오디는 현재 당뇨병, 대머리, 숙취, 고혈압 및 염증 등의 치료에 사용되고 있다. 또한 오디는 음료, 젤리 및 잼과 같은 기호 식품에서 중요한 당, 유기산, 안토시아닌 등이 풍부하며, 항당뇨, 항고혈암, 항종양, 항산화 및 항노화 활성을 갖는, 1-데옥시노지리마이신(DNJ), γ-아미노부티르산(GABA), 카페산, 라스베라트롤 유도체, 플라보노이드 및 아릴벤조푸란을 포함하는 다수의 중요 생리활성물질을 함유하고 있다.In Korean traditional medicine, two types of mulberry, Morus alba (MA) and Cudramia tricuspidata ) (CT) has been widely used. Audi, the fruit of mulberry (MA), is currently used to treat diabetes, baldness, hangover, high blood pressure and inflammation. Audi is also rich in sugars, organic acids, anthocyanins, etc., which are important in favorite foods such as beverages, jelly and jams, and have 1-deoxynozirimycin (DNJ), which has antidiabetic, antihypercarcinoma, antitumor, antioxidant and anti-aging activities. ), γ-aminobutyric acid (GABA), caffeic acid, rasveratrol derivatives, flavonoids and arylbenzofuran.
한편, 꾸지뽕 나무(CT)는 최근 들어 피부 자극뿐만 아니라 항암, 항염증, 항신경염 및 항균 치료제로서 연구되고 있다. 프레닐화 크산톤 및 플라보노이드와 같은 몇몇 생리활성물질들이 주로 CT의 중요 생물학적 효과 원인이 되는 것으로 보고되었다. On the other hand, kkujippong tree (CT) has recently been studied as an anticancer, anti-inflammatory, anti-neuritis and antimicrobial treatment as well as skin irritation. Several bioactive substances, such as prenylated xanthones and flavonoids, have been reported to be the major cause of important biological effects of CT.
꾸지뽕 나무의 생리활성과 관련하여, 오 등의 보고[오필선 , 이혜진, 임계택; RBL-2H3 세포에 있어서 꾸지뽕 당단백질에 의한 히스타민 방출 및 COX-2 활성 억제 효과; 한국식품과학회지 제41권 제4호 통권 제206호 (2009년 8월) pp.405-412 0367-6293]에 꾸지뽕 당단백질이 항 알레르기 효능을 갖는 물질로서 알레르기성 비염, 아토피 등과 같은 알레르기 관련 질환의 예방 및 치료제로 사용될 수 있을 것이라는 내용이 개시되어 있으며, 주 등의 보고[주헌영, 임계택; 한국식품과학회지 제41권 제1호 통권 제203호 (2009년 2월) pp.93-99 0367-6293]에 꾸지뽕 당단백질은 탁월한 천연 항산화제로서 간의 독성 및 염증 반응을 억제할 수 있음이 개시되어 있다.In relation to the physiological activity of Cudrania japonica, Oh et al. Inhibitory effect of histamine release and COX-2 activity by kkujippong glycoprotein in RBL-2H3 cells; Korean Journal of Food Science and Technology, Vol. 41, No. 4, No. 206 (August 2009) pp.405-412 0367-6293] is a substance in which KUJIJUNG glycoprotein has antiallergic effect. It is disclosed that it can be used as a prophylaxis and treatment of diseases, reports of the state, such as [Jun Heon-young, Jeon Ji-taek; Korean Journal of Food Science and Technology, Vol. 41, No. 1, No. 203 (February 2009) pp.93-99 0367-6293], KUJIJUNG glycoprotein is an excellent natural antioxidant that can suppress liver toxicity and inflammatory reactions. Is disclosed.
또한, 대한민국 특허출원 제10-2002-0030093호 ‘C형 간염 활성 억제를 갖는 꾸지뽕 추출물을 포함하는 조성물’에 C형 간염의 예방 및 치료 효과를 나타내는 꾸지뽕(Maclura tricuspidata CARR.)의 극성 및 비극성 용매 가용 추출물이 개시되어 있다.In addition, Republic of Korea Patent Application No. 10-2002-0030093 'composition comprising a kkujippong extract having inhibitory hepatitis C activity' kkujippong ( Maclura) showing the prevention and treatment effect of hepatitis C polar and nonpolar solvent soluble extracts of tricuspidata CARR.) are disclosed.
이 밖에 꾸지뽕을 이용한 기술로는 꾸지뽕 기름 추출, 정제방법 및 장치 (대한민국 특허출원 제10-2008-0039349호), 꾸지뽕 기름 추출, 정제방법 및 장치 (대한민국 특허출원 제10-2002-0082420호), 꾸지뽕 차 및 그 제조방법(대한민국 특허출원 제10-2008-0052258호), 찰보리와 꾸지뽕 등의 각종 한방재료를 이용한 찰보리빵의 제조방법(대한민국 특허출원 제10-2007-0112507호) 등이 개시되어 있다.In addition, as a technique using kkujippong, kkujippong oil extraction, purification method and device (Korean Patent Application No. 10-2008-0039349), kkujippong oil extraction, purification method and device (Korea Patent Application No. 10-2002-0082420), Kujippong tea and a manufacturing method thereof (Korean Patent Application No. 10-2008-0052258), a manufacturing method of the wax barley bread using various herbal ingredients such as chalbary and jjjippong (Korean Patent Application No. 10-2007-0112507) have.
지금까지, 상기 두 가지 유형의 뽕나무의 다양한 부분으로부터 생물학적으로 활성인 화합물을 스크리닝하는데 있어 많은 연구가 수행되어 왔다. 그러나 뽕나무 주스 및 와인 생산과정에서 부산물로 얻어진 씨앗의 기능성 성분이나 생물학적 활성에 대해 유용한 정보는 거의 없는 실정이다. To date, much research has been conducted in screening biologically active compounds from various parts of the two types of mulberry. However, there is little useful information on the functional components and biological activities of seeds obtained as by-products from mulberry juice and wine production.
따라서, 본 발명자들은 뽕나무 열매 부산물인 씨앗으로부터 기능성 성분과 생물학적 활성을 동정하고, 이들의 생리활성을 확인하기 위해 예의 연구를 거듭한 결과, 오디와 꾸지뽕 열매 씨앗으로부터 오일과 추출물을 얻고 이들로부터 폴리페놀 화합물을 정량하고, 이들의 생리활성을 확인함으로써 본 발명을 완성하게 되었다.
Therefore, the inventors of the present invention have repeatedly studied to identify functional components and biological activities from the seeds of the mulberry fruit by-products, and to confirm their physiological activity. The present invention has been completed by quantifying the compounds and confirming their physiological activity.
따라서 본 발명의 목적은 뽕나무 열매 씨앗 추출물을 유효성분으로 함유하는 당뇨병 치료 또는 예방용 약제학적 조성물을 제공하는 것이다.Therefore, it is an object of the present invention to provide a pharmaceutical composition for treating or preventing diabetes containing the mulberry fruit seed extract as an active ingredient.
본 발명의 다른 목적은 또한 뽕나무 열매 씨앗 추출물을 유효성분으로 함유하는 항산화, 항당뇨 또는 항노화 활성 건강기능식품 조성물을 제공하는 것이다.Another object of the present invention is to provide an antioxidant, anti-diabetic or anti-aging active dietary supplement composition containing the mulberry fruit seed extract as an active ingredient.
본 발명의 다른 목적은 뽕나무 열매 씨앗 추출물을 유효성분으로 함유하는 항산화 또는 항노화 활성 화장료 조성물을 제공하는 것이다.
Another object of the present invention is to provide an antioxidant or anti-aging active cosmetic composition containing the mulberry fruit seed extract as an active ingredient.
상기와 같은 본 발명의 목적은 뽕나무(Morus alba)(MA) 열매 또는 꾸지뽕나무(Cudramia tricuspidata)(CT) 열매 씨앗으로부터 오일 및 MeOH 추출물을 제조하고, 이들의 지방산 조성, 토코페롤 및 피토스테롤을 분석하고, 총 폴리페놀과 총 플라보노이드 함량을 측정하는 한편, 이들의 항산화, 항당뇨 및 항노화 활성을 측정하여 오디 및 꾸지뽕 열매 씨앗 추출물은 높은 수준의 폴리페놀 및 플라보노이드 함량과 강력한 생물학적 활성을 나타내어 항산화, 항당뇨 및 항노화 활성에 매우 효과적일 수 있음을 확인함으로써 달성되었다.The object of the present invention as described above Mulberry ( Morus alba ) (MA) fruit or Cudramia tricuspidata ) (CT) Prepare oil and MeOH extracts from fruit seeds, analyze their fatty acid composition, tocopherols and phytosterols, determine total polyphenol and total flavonoid content, while their antioxidant, antidiabetic and anti-aging activities It was achieved by confirming that the mulberry and Cudrania fruit seed extracts exhibited high levels of polyphenol and flavonoid content and potent biological activity, which could be very effective for antioxidant, antidiabetic and anti-aging activities.
본 발명은 뽕나무 열매 씨앗 추출물을 유효성분으로 함유하는 당뇨병 치료 또는 예방용 약제학적 조성물을 제공한다.The present invention provides a pharmaceutical composition for treating or preventing diabetes containing the mulberry fruit seed extract as an active ingredient.
본 발명은 또한 뽕나무 열매 씨앗 추출물을 유효성분으로 함유하는 항산화, 항당뇨 또는 항노화 활성 건강기능식품 조성물을 제공한다.The present invention also provides an antioxidant, antidiabetic or anti-aging active health food composition containing the mulberry fruit seed extract as an active ingredient.
본 발명은 또한 뽕나무 열매 씨앗 추출물을 유효성분으로 함유하는 항산화, 또는 항노화 활성 화장료 조성물을 제공한다.The present invention also provides an antioxidant or anti-aging active cosmetic composition containing the mulberry fruit seed extract as an active ingredient.
본 발명에 있어서, 상기 뽕나무 열매 씨앗은 뽕나무(Morus alba)(MA) 열매 또는 꾸지뽕나무(Cudramia tricuspidata)(CT) 열매 씨앗인 것을 특징으로 한다.In the present invention, the mulberry fruit seeds are mulberry ( Morus alba ) (MA) fruit or Cudramia tricuspidata ) (CT) Fruit seed.
본 발명에 있어서, 상기 뽕나무 열매 씨앗 추출물은 뽕나무 열매 씨앗 오일 추출물 또는 MeOH 추출물인 것을 특징으로 한다.
In the present invention, the mulberry fruit seed extract is characterized in that the mulberry fruit seed oil extract or MeOH extract.
본 발명에 있어서, "유효성분"이라 함은 내재된 약리작용에 의해 그 의약품의 효능?효과를 직접 또는 간접적으로 발현한다고 기대되는 물질 또는 물질군(약리학적 활성성분 등이 밝혀지지 않은 생약 등을 포함한다)으로서 주성분을 포함하는 것을 의미한다.In the present invention, the term "active ingredient" refers to a substance or a group of substances (a pharmacologically active ingredient or the like, which is expected to express directly or indirectly the efficacy and effect of the drug by intrinsic pharmacological action). It means containing a main component).
본 발명에 있어서, "건강기능식품"은 건강기능식품에 관한 법률 제6727호에 따른 인체에 유용한 기능성을 가진 원료나 성분을 사용하여 제조 및 가공한 식품을 의미하며, "기능성"이라 함은 인체의 구조 및 기능에 대하여 영양소를 조절하거나 생리학적 작용 등과 같은 보건 용도에 유용한 효과를 얻을 목적으로 섭취하는 것을 의미한다.In the present invention, "health functional food" means a food manufactured and processed using raw materials or ingredients having functional properties useful for the human body according to the Health Functional Food Act No. 6767, and "functional" means a human body It means the ingestion for the purpose of obtaining a useful effect in health use such as nutrient control or physiological action on the structure and function of.
본 발명의 뽕나무 열매 씨앗 추출물을 포함하는 약제학적 조성물은 약학적 조성물의 제조에 통상적으로 사용하는 적절한 담체, 부형제 및 희석제를 더 포함할 수 있다.Pharmaceutical compositions comprising the mulberry fruit seed extract of the present invention may further comprise suitable carriers, excipients and diluents commonly used in the manufacture of pharmaceutical compositions.
본 발명의 뽕나무 열매 씨앗 추출물을 포함하는 약제학적 조성물은, 각각 통상의 방법에 따라 산제, 과립제, 정제, 캡슐제, 현탁액, 에멀젼, 시럽, 에어로졸 등의 경구형 제형, 외용제, 좌제 및 멸균 주사용액의 형태로 제형화하여 사용될 수 있다. Pharmaceutical compositions comprising the mulberry fruit seed extract of the present invention, oral formulations, external preparations, suppositories, and sterile injectables such as powders, granules, tablets, capsules, suspensions, emulsions, syrups, aerosols, respectively, according to a conventional method Formulated in the form of can be used.
본 발명의 뽕나무 열매 씨앗 추출물을 포함하는 약제학적 조성물에 포함될 수 있는 담체, 부형제 및 희석제로는 락토즈, 덱스트로즈, 수크로스, 솔비톨, 만니톨, 자일리톨, 에리스리톨, 말티톨, 전분, 아카시아 고무, 알지네이트, 젤라틴, 칼슘 포스페이트, 칼슘 실리케이트, 셀룰로즈, 메틸셀룰로즈, 미정질 셀룰로스, 폴리비닐 피롤리돈, 물, 메틸히드록시벤조에이트, 프로필히드록시벤조에이트, 탈크, 마그네슘 스테아레이트 및 광물유를 들 수 있다. 제제화할 경우에는 보통 사용하는 충진제, 증량제, 결합제, 습윤제, 붕해제, 계면활성제 등의 희석제 또는 부형제를 사용하여 조제된다. Carriers, excipients and diluents that may be included in the pharmaceutical composition comprising the mulberry fruit seed extract of the present invention include lactose, dextrose, sucrose, sorbitol, mannitol, xylitol, erythritol, maltitol, starch, acacia rubber, alginate , Gelatin, calcium phosphate, calcium silicate, cellulose, methylcellulose, microcrystalline cellulose, polyvinyl pyrrolidone, water, methylhydroxybenzoate, propylhydroxybenzoate, talc, magnesium stearate and mineral oil. When formulated, diluents or excipients such as fillers, extenders, binders, wetting agents, disintegrating agents, and surfactants are usually used.
경구투여를 위한 고형제제에는 정제, 환제, 산제, 과립제, 캡슐제 등이 포함되며, 이러한 고형제제는 상기 추출액에 적어도 하나 이상의 부형제 예를 들면, 전분, 칼슘카보네이트(calciumcarbonate), 수크로스(sucrose) 또는 락토오스(lactose), 젤라틴 등을 섞어 조제된다. 또한 단순한 부형제 이외에 마그네슘 스테아레이트, 탈크 같은 윤활제들도 사용된다. Solid preparations for oral administration include tablets, pills, powders, granules, capsules, and the like, and the solid preparations include at least one excipient such as starch, calcium carbonate, sucrose in the extract. Or lactose, gelatin, or the like is mixed. In addition to simple excipients, lubricants such as magnesium stearate and talc are also used.
경구투여를 위한 액상 제제로는 현탁제, 내용액제, 유제, 시럽제 등이 해당되는데 흔히 사용되는 단순희석제인 물, 리퀴드 파라핀 이외에 여러 가지 부형제, 예를 들면 습윤제, 감미제, 방향제, 보존제 등이 포함될 수 있다. Liquid preparations for oral administration include suspensions, solutions, emulsions, and syrups, and various excipients, such as wetting agents, sweeteners, fragrances, and preservatives, in addition to commonly used simple diluents such as water and liquid paraffin. have.
비경구 투여를 위한 제제에는 멸균된 수용액, 비수성용제, 현탁제, 유제, 동결건조 제제, 좌제가 포함된다. 비수성용제, 현탁제로는 프로필렌글리콜(propylene glycol), 폴리에틸렌 글리콜, 올리브 오일과 같은 식물성 기름, 에틸올레이트와 같은 주사 가능한 에스테르 등이 사용될 수 있다. 좌제의 기제로는 위텝솔(witepsol), 마크로골, 트윈(tween) 61, 카카오지, 라우린지, 글리세로제라틴 등이 사용될 수 있다.Formulations for parenteral administration include sterile aqueous solutions, non-aqueous solvents, suspensions, emulsions, lyophilized preparations, suppositories. As the non-aqueous solvent and suspending agent, propylene glycol, polyethylene glycol, vegetable oil such as olive oil, injectable ester such as ethyl oleate and the like can be used. As the base of the suppository, witepsol, macrogol, tween 61, cacao butter, laurin butter, glycerogelatin and the like can be used.
본 발명에 따른 뽕나무 열매 씨앗 추출물의 바람직한 투여량은 환자의 상태 및 체중, 질병의 정도, 약물형태, 투여경로 및 기간에 따라 다르지만, 당업자에 의해 적절하게 선택될 수 있다. 그러나 바람직한 효과를 위해서, 본 발명의 뽕나무 열매 씨앗 추출물은 1일 0.0001 내지 100 mg/kg으로, 바람직하게는 0.001 내지 100 mg/kg으로 투여하는 것이 좋다. 투여는 하루에 한번 투여할 수도 있고, 수회 나누어 투여할 수도 있다. 상기 투여량은 어떠한 면으로든 본 발명의 범위를 한정하는 것은 아니다.The preferred dosage of the mulberry fruit seed extract according to the present invention depends on the condition and weight of the patient, the extent of the disease, the form of the drug, the route of administration and the duration, and may be appropriately selected by those skilled in the art. However, for the desired effect, the mulberry fruit seed extract of the present invention is preferably administered in 0.0001 to 100 mg / kg, preferably 0.001 to 100 mg / kg per day. Administration may be administered once a day or may be divided several times. The dosage does not limit the scope of the invention in any aspect.
본 발명에 따른 뽕나무 열매 씨앗 추출물은 쥐, 생쥐, 가축, 인간 등의 포유동물에 다양한 경로로 투여될 수 있다. 투여의 모든 방식이 예상될 수 있는데, 예를 들면, 경구, 직장 또는 정맥, 근육, 피하, 자궁내 경막 또는 뇌혈관내(intracerebroventricular) 주사 및 피부에 직접 투여될 수 있다. Mulberry fruit seed extract according to the present invention can be administered to various mammals such as mice, mice, livestock, humans. All modes of administration can be expected, for example, oral, rectal or intravenous, intramuscular, subcutaneous, intrauterine dural or intracerebroventricular injections and directly to the skin.
또한, 본 발명에 따른 뽕나무 열매 씨앗 추출물은 당뇨병의 예방 및 개선 효과를 목적으로 식품 또는 음료에 첨가될 수 있다. 뽕나무 열매 씨앗 추출물을 첨가할 수 있는 식품으로는, 예를 들어, 각종 식품류, 음료, 껌, 차, 비타민 복합제, 건강 기능성 식품류, 분말, 과립, 정제, 캡슐 또는 음료 등이 있다. 이 때, 식품 또는 음료 중의 상기 뽕나무 열매 씨앗 추출물의 양은 전체 식품 중량의 0.01 내지 15 중량%로 가할 수 있으며, 건강 음료 조성물은 100 ㎖를 기준으로 0.02 내지 5 g, 바람직하게는 0.3 내지 1 g의 비율로 가할 수 있다.In addition, the mulberry fruit seed extract according to the present invention may be added to food or beverage for the purpose of preventing and improving diabetes. Examples of the food to which the mulberry fruit seed extract can be added include various foods, beverages, gums, teas, vitamin complexes, health functional foods, powders, granules, tablets, capsules or beverages. At this time, the amount of the mulberry fruit seed extract in the food or beverage may be added to 0.01 to 15% by weight of the total food weight, the health beverage composition is 0.02 to 5 g, preferably 0.3 to 1 g based on 100 ml Can be added in proportion.
본 발명의 식품 조성물은 지시된 비율로 필수 성분으로서 뽕나무 열매 씨앗 추출물을 함유하는 외에는 다른 성분에는 특별한 제한이 없으며 통상의 음료와 같이 여러 가지 향미제 또는 천연 탄수화물 등을 추가 성분으로서 함유할 수 있다. 상술한 천연 탄수화물의 예는 모노사카라이드, 예를 들어, 포도당, 과당 등; 디사카라이드, 예를 들어 말토스, 슈크로스 등; 및 폴리사카라이드, 예를 들어 덱스트린, 시클로덱스트린 등과 같은 통상적인 당, 및 자일리톨, 소르비톨, 에리트리톨 등의 당알콜이다. 상술한 것 이외의 향미제로서 천연 향미제(타우마틴, 스테비아 추출물(예를 들어 레바우디오시드 A, 글리시르히진 등) 및 합성 향미제(사카린, 아스파르탐 등)를 유리하게 사용할 수 있다. 상기 천연 탄수화물의 비율은 본 발명의 조성물 100 ㎖당 일반적으로 약 1 내지 20g, 바람직하게는 약 5 내지 12g이다. The food composition of the present invention is not particularly limited to other ingredients except the mulberry fruit seed extract as an essential ingredient in the indicated ratio, and may contain various flavors or natural carbohydrates, etc. as additional ingredients, such as ordinary drinks. Examples of the above-mentioned natural carbohydrates include monosaccharides such as glucose, fructose and the like; Disaccharides such as maltose, sucrose and the like; And conventional sugars such as polysaccharides such as dextrin, cyclodextrin, and sugar alcohols such as xylitol, sorbitol, and erythritol. As flavoring agents other than those described above, natural flavoring agents (tauumatin, stevia extract (e.g., Rebaudioside A, glycyrrhizin, etc.) and synthetic flavoring agents (saccharin, aspartame, etc.) can be advantageously used. The proportion of said natural carbohydrates is generally about 1-20 g, preferably about 5-12 g per 100 ml of the composition of the present invention.
상기 외에 본 발명의 뽕나무 열매 씨앗 추출물은 여러 가지 영양제, 비타민, 광물(전해질), 합성 풍미제 및 천연 풍미제 등의 풍미제, 착색제 및 중진제(치즈, 초콜릿 등), 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알콜, 탄산음료에 사용되는 탄산화제 등을 함유할 수 있다. In addition to the above, the mulberry fruit seed extract of the present invention is a variety of nutrients, vitamins, minerals (electrolytes), synthetic and natural flavors, such as flavoring agents, coloring and neutralizing agents (such as cheese, chocolate), pectic acid and salts thereof, Alginic acid and salts thereof, organic acids, protective colloidal thickeners, pH adjusters, stabilizers, preservatives, glycerin, alcohols, carbonation agents used in carbonated beverages, and the like.
그밖에 본 발명의 뽕나무 열매 씨앗 추출물은 천연 과일 주스 및 과일 주스 음료 및 야채 음료의 제조를 위한 과육을 함유할 수 있다. 이러한 성분은 독립적으로 또는 조합하여 사용할 수 있다. 이러한 첨가제의 비율은 그렇게 중요하진 않지만 본 발명의 뽕나무 열매 씨앗 추출물은 100 중량부 당 0 내지 약 20 중량부의 범위에서 선택되는 것이 일반적이다.In addition, the mulberry fruit seed extract of the present invention may contain the flesh for the production of natural fruit juices and fruit juice drinks and vegetable drinks. These components can be used independently or in combination. The proportion of such additives is not so important, but the mulberry fruit seed extract of the present invention is generally selected in the range of 0 to about 20 parts by weight per 100 parts by weight.
본 발명의 화장료 조성물은 생리학적으로 허용가능한 매체, 예를 들어, 지방 물질, 보존제, 비타민, 젤화제, 향료, 계면활성제, 물, 산화방지제, 충전재, 습윤제, 차폐제 및 이들의 혼합물을 추가로 포함할 수 있다.Cosmetic compositions of the present invention further comprise physiologically acceptable media such as fatty substances, preservatives, vitamins, gelling agents, flavoring agents, surfactants, water, antioxidants, fillers, wetting agents, masking agents and mixtures thereof. can do.
본 발명에 따른 화장료 조성물은 기초화장용 또는 메이크업용 제품류인 화장수류, 에센스류, 크림류, 로션류, 팩류, 파운데이션류, 메이크업베이스류 등의 제형으로 제조되어 이용될 수 있다. 액상, 크림상, 페이스트상, 고체상 등 다양한 성상으로 적용이 가능하며, 통상적인 화장료 제조법으로 제조될 수 있다. The cosmetic composition according to the present invention may be prepared and used in the formulation of cosmetics, cosmetics, makeup products, essences, creams, lotions, packs, foundations, makeup bases and the like. It can be applied in various forms such as liquid, cream, paste, solid, and can be prepared by a conventional cosmetic preparation method.
본 발명에 따른 화장료 조성물은 뽕나무 열매 씨앗 추출물을 건조 중량으로서 1 내지 10 중량%, 바람직하게는 1 내지 5 중량%의 양을 화장료 제조 시 첨가한다. The cosmetic composition according to the present invention adds 1 to 10% by weight, preferably 1 to 5% by weight, of the mulberry fruit seed extract as a dry weight when preparing cosmetics.
본 발명에서는 두 가지 뽕나무 열매인 오디와 꾸지뽕 열매의 씨앗의 오일 함량과, 지방산, 토코페롤 및 피토스테롤 조성 및 함량을 측정하였다. 또한 탈지한 오디 및 꾸지뽕 열매 씨앗 잔사 추출물의 폴리페놀 화합물 및 생물학적 활성을 평가하였다. 오디 및 꾸지뽕 열매 씨앗의 오일 함량은 각각 29.63% 및 16.69%였으며, 탈지된 오디 및 꾸지뽕 열매 씨앗 잔사 MeOH 추출물은 각각 5.10% 및 6.22%였다. 상기 두 가지 씨앗 오일은 74.37 및 81.4%의 리놀레산, 5.75 및 11.39%의 올레산, 8.40 및 10.18%의 팔미트산 및 3.0 및 3.52%의 스테아르산과 두 가지 미량의 지방산인 리놀렌산 및 아라키드산으로 이루어졌다. 오디 씨앗은 꾸지뽕 씨앗 보다 높은 함량의 피토스테롤(507.59 mg/100g of oil), 토코페롤(99.64 mg/100g of oil) 및 총 플라보노이드(106.50 mg/100g of oil)을 함유하였으며, 반면 꾸지뽕 씨앗이 오디 씨앗 보다 높은 수준의 총 폴리페놀을 함유하였다. 오디 씨앗 잔사의 MeOH 추출물이 꾸지뽕 열매 씨앗 잔사 보다 높은 항산화, 항당뇨 및 항노화 활성을 나타내었다. t-레스베라트롤(9.62mg/100g of oil), 쿼세틴(54.83mg/100g of oil) 및 4-프레릴모라신(48.70mg/100g of oil)이 오디 씨앗 잔사 MeOH 추출물의 주요 폴리페놀 성분인 것으로 밝혀졌다.In the present invention, the oil content, fatty acid, tocopherol and phytosterol composition and content of the seeds of two mulberry fruits, Audi and Cudrania fruit, were measured. In addition, polyphenol compounds and biological activities of the degreased mulberry and Cudrania fruit seed residue extracts were evaluated. The oil contents of the Audi and Cudrania fruit seeds were 29.63% and 16.69%, respectively, and the defatted Audi and Cudrania Fruit Seed residue MeOH extracts were 5.10% and 6.22%, respectively. The two seed oils consisted of 74.37 and 81.4% linoleic acid, 5.75 and 11.39% oleic acid, 8.40 and 10.18% palmitic acid and 3.0 and 3.52% stearic acid and two trace fatty acids linolenic acid and arachidic acid. . Audi seeds contained higher levels of phytosterols (507.59 mg / 100g of oil), tocopherols (99.64 mg / 100g of oil) and total flavonoids (106.50 mg / 100g of oil) than courageous seeds, whereas Contains high levels of total polyphenols. MeOH extract of the mulberry seed residue showed higher antioxidant, antidiabetic and anti-aging activity than the Cudrania fruit seed residue. t-resveratrol (9.62mg / 100g of oil), quercetin (54.83mg / 100g of oil) and 4-prelylamorin (48.70mg / 100g of oil) are found to be the main polyphenolic components of the Audi seed residue MeOH extract lost.
이와 같이 본 발명에서는 오디 씨앗이 꾸지뽕 열매 씨앗 보다 높은 식물 생리활성 물질 함량과 생물학적 활성을 나타내었으며, 오디 씨앗이 풍부한 토코페롤 및 피토스테롤 양으로 우수한 필수 지방산 공급원인 것으로 나타났다. 이와 같은 오디 씨앗 잔사의 높은 수준의 폴리페놀 및 플라보노이드 함량과 강력한 생물학적 활성은 천연 항산화제의 식이 공급원으로서 유용할 수 있다. 특히 오디 씨앗이 항암, 항고혈압 및 항당뇨 활성을 갖는 레스베라트롤, 쿼세틴 및 4-프레릴모라신을 높은 농도로 함유함으로써 뽕나무 열매 전체의 소비가 몇 가지 병리적 질환, 예를 들어, 관상 심장 질환, 당뇨병, 죽종형성, 암 및 노화를 방지하는데 중요한 역할을 할 수 있을 것이다.
Thus, in the present invention, the mulberry seeds showed higher plant bioactive substance content and biological activity than the Cudrania fruit seeds, and were found to be an excellent source of essential fatty acids in abundant tocopherol and phytosterol amounts. Such high levels of polyphenol and flavonoid content and potent biological activity of the mulberry seed residue may be useful as dietary sources of natural antioxidants. In particular, mulberry seeds consume high amounts of resveratrol, quercetin and 4-prelylacin with high levels of anticancer, antihypertensive and antidiabetic activity, leading to consumption of the mulberry fruit in several pathological diseases, for example, coronary heart disease, diabetes. It may play an important role in preventing atherosclerosis, cancer and aging.
상기한 바와 같이 본 발명에 따른 오디 및 꾸지뽕 열매 씨앗 추출물은 높은 수준의 폴리페놀 및 플라보노이드 함량과 강력한 생물학적 활성을 나타내어 항산화, 항당뇨 및 항노화 활성에 매우 효과적이어서 우수한 필수 지방산 공급원 또는 천연 항산화제의 식이 공급원으로서 유용한 효과가 있다.
As described above, the mulberry seed extract according to the present invention exhibits a high level of polyphenol and flavonoid content and strong biological activity, which is very effective for antioxidant, antidiabetic and anti-aging activity, and thus is an excellent source of essential fatty acid or natural antioxidant. There is a useful effect as a dietary source.
도 1은 일곱가지 표준 페놀 화합물(A) 와 오디 씨앗 잔사의 MeOH 추출물의 HPLC 크로마토그램을 나타낸 도이다. 5: t-레스베라트롤, 6: 쿼세틴, 7: 4-프레릴모라신1 is a diagram showing HPLC chromatograms of seven standard phenolic compounds (A) and MeOH extract of Audi seed residue. 5: t -resveratrol, 6: quercetin, 7: 4-prerylmoracin
이하에서 본 발명의 바람직한 실시형태를 실시예를 참고로 보다 구체적으로 설명한다. 하지만 본 발명의 범위가 이러한 실시예에 한정되는 것은 아니다.
Hereinafter, preferred embodiments of the present invention will be described in more detail with reference to Examples. However, the scope of the present invention is not limited to these examples.
실시예Example
이하 실시예에서 뽕나무(Morus alba)(MA) 열매(이하에서 ‘오디’로 칭함)와 꾸지뽕나무(Cudramia tricuspidata)(CT) 열매(이하에서 ‘꾸지뽕 열매’로 칭함)의 씨앗은 주스 생산 동안 산출된 다량의 압착 잔사에서 얻었다. 상기 각각의 잔사에서 두 종류의 씨앗을 분리하고, 흐르는 물로 씻은 후 실온에서 자연건조하였다. Morus ( Morus) in the following examples alba ) (MA) fruit (hereinafter referred to as 'audio') and Cudramia Seeds of tricuspidata ) (CT) fruit (hereinafter referred to as 'Cujippong fruit') were obtained from a large amount of pressed residues produced during juice production. Two kinds of seeds were separated from each residue, washed with running water, and then dried at room temperature.
유리 지방산, 네 가지 토코페롤 이성질체(α-, β-, γ- 및 δ-토코페롤), 세 가지 피토스테롤(캄페스테롤, 스티그마스테롤, β-시토스테롤), 1,l-디페닐-2-피크릴히드라질(DPPH), α-글루코시다제, 머쉬룸 티로시나제, 쿼세틴, 루틴, L-디하이드록시페닐알라닌(L-DOPA) 및 t-레스베라트롤은 시그마 케미칼사(Signa Chemical Co.; St. Louis, Mo, USA)에서 구입하였다. 수산화 칼륨, 염화 알루미늄, 폴린-시오칼테우 페놀 시약(Folin-Ciocalteau's phenol reagent) 및 t-부틸화하이드록시톨루엔(BHT)는 와코 퓨어 케미칼사(Wako Pure Chemicla Ind.; Osaka, Japan)에서 구입하였다. HPLC 용매를 머크사(Merck; Darmstadt, Germany)에서 구입하였다. 이 밖에 본 발명에서 사용한 다른 모든 시약은 분석 등급의 것들을 사용하였다.
Free fatty acids, four tocopherol isomers (α-, β-, γ-, and δ-tocopherol), three phytosterols (camphorsterol, stigmasterol, β-sitosterol), 1, l-diphenyl-2-picrylhydrazil (DPPH), α-glucosidase, mushroom tyrosinase, quercetin, rutin, L-dihydroxyphenylalanine (L-DOPA) and t-resveratrol are Signa Chemical Co .; St. Louis, Mo, USA Purchased from Potassium hydroxide, aluminum chloride, Folin-Ciocalteau's phenol reagent and t-butylated hydroxytoluene (BHT) were purchased from Wako Pure Chemicla Ind .; Osaka, Japan. . HPLC solvents were purchased from Merck (Darmstadt, Germany). All other reagents used in the present invention were those of analytical grade.
실시예 1 : 오일 및 Example 1: Oil and MeOHMeOH 추출물 제조 Extract manufacturer
본 실시예에서는 오디와 꾸지뽕 열매의 씨앗을 각각 분말화하고, 얻어진 씨앗 분말(10g)을 0.05% BHT 함유 페트롤륨 에테르(100 mL)로 1 시간 동안 초음파 클리너(Bransonic 5210R-DTH, USA)에서 2회 추출하고, 여과지(Whatman No. 2; Whatman Laboratory Products, Clifon, NL, USA)로 여과한 후, 마지막으로 감압 하에서 용매를 증발시켰다. 오일 성분은 씨앗 건조 중량을 기준으로 나타내었다. In this example, the seeds of Audi and Cudrania fruit were respectively powdered, and the obtained seed powder (10 g) was treated with 0.05% BHT containing petroleum ether (100 mL) for 1 hour in an ultrasonic cleaner (Bransonic 5210R-DTH, USA). Extracted once, filtered through filter paper (Whatman No. 2; Whatman Laboratory Products, Clifon, NL, USA), and finally the solvent was evaporated under reduced pressure. Oil components are shown based on seed dry weight.
한편, 오일 추출 후 얻어진 두 가지 씨앗 잔사는 90% MeOH 수용액(200 mL)로 2 시간 동안 초음파 클리너에서 2회 추출하고, 여과한 후, 진공에서 용매를 증발시켰다. 조 MeOH 추출물을 동일 용매에 용해시켜 냉장상태로 밤새 정치시킨 후 얻어진 용액을 3,000 rpm에서 30분 동안 원심분리하고, 상층을 진공에서 증발시켜 MeOH 추출물을 수득하였다. Meanwhile, the two seed residues obtained after oil extraction were extracted twice with an ultrasonic cleaner for two hours with an aqueous 90% MeOH solution (200 mL), filtered, and the solvent was evaporated in vacuo. The crude MeOH extract was dissolved in the same solvent and allowed to stand overnight in refrigerated state, and the resulting solution was centrifuged at 3,000 rpm for 30 minutes, and the upper layer was evaporated in vacuo to give a MeOH extract.
오디와 꾸지뽕 열매 씨앗의 오일과 MeOH 추출물의 수율(%)을 하기 표 1에 나타내었다. Yields (%) of oil and MeOH extract of Audi and Cudrania fruit seeds are shown in Table 1 below.
컬럼에서 첨자로 표기된 값은 p < 0.05에서 유의적으로 상이함Each figure is the mean ± SD of three analyzes
Subscripted values in columns differ significantly at p <0.05
오디 씨앗의 오일 및 MeOH 추출물의 수율은 각각 29.36 및 5.10%인 반면, 꾸지뽕 열매 씨앗의 오일 및 MeOH 추출물의 수율은 각각 16.69 및 6.22%였다. 이로부터, 오디 씨앗의 오일 추출물의 수율이 꾸지뽕 열매 씨앗의 오일 추출물의 수율 보다 유의적으로 높은 반면, 오디 씨앗 잔사의 MeOH 추출물의 수율이 꾸지뽕 열매 씨앗 잔사의 MeOH 추출물의 수율보다 다소 낮았음을 알 수 있다. The yields of oil and MeOH extracts of Audi seeds were 29.36 and 5.10%, respectively, while the yields of oil and MeOH extracts of Cudrania fruit seeds were 16.69 and 6.22%, respectively. From this, it was found that the yield of the oil extract of the Audi seed was significantly higher than the yield of the oil extract of the Cucumis fruit seeds, while the yield of the MeOH extract of the Audi seed residue was somewhat lower than the yield of the MeOH extract of the Cuzipan fruit seed residue. Can be.
이러한 데이터는 식물 유형, 품종, 숙성도 및 가공여부에 따라 식물 씨앗의 오일 및 MeOH 추출물의 수율이 다양함을 지지하는 것이다. 오디 씨앗이 꾸지뽕 열매 씨앗을 포함해 다른 식물 씨앗 보다 높은 오일 함량을 가지고 있다는 점이 주목된다. 뽕나무 주스의 가공 과정에서 부산물로 얻어진 오디 씨앗의 수율은 오디 열매 100g 당 약 3-5%였다.
These data support the varying yields of oil and MeOH extracts of plant seeds depending on plant type, variety, maturity and processing. It is to be noted that the Audi seeds have a higher oil content than other plant seeds, including Cudrania seeds. The yield of mulberry seeds obtained as a by-product during the processing of mulberry juice was about 3-5% per 100 g of mulberry fruit.
실험예Experimental Example
이하의 실험예에서는 상기 실시예에서 수득한 오디 및 꾸지뽕 열매 씨앗의 오일 및 MeOH 추출물에 대한 지방산 조성 분석, 토코페롤 분석, 피토스테롤 분석, 총 폴리페놀 및 플라보노이드 함량 측정, 항산화, 항당뇨 및 항노화 활성 분석, 페놀 화합물 정량을 수행하였다.In the following experimental examples, fatty acid composition analysis, tocopherol analysis, phytosterol analysis, total polyphenol and flavonoid content measurement, antioxidant, antidiabetic and anti-aging activity analysis of the oil and MeOH extracts of the mulberry seed and zigzag fruit seeds obtained in the above examples , Phenolic compound quantification was performed.
모든 데이터는 개별적으로 3회 분석한 각 씨앗의 두 가지 시료에 대한 평균±표준편차(SD)로 나타내었다. IC50 값은 시료의 세 가지 상이한 농도에서 얻은 결과의 회귀 분석으로 측정하였다. 통계적 분석은 p<0.05에서 던컨 다중 범위 시험법을 이용하여 수행하였다.
All data are presented as mean ± standard deviation (SD) for two samples of each seed, analyzed three times individually. IC 50 values were determined by regression analysis of results obtained at three different concentrations of samples. Statistical analysis was performed using Duncan's multi-range test at p <0.05.
실험예 1 : 지방산 조성 분석Experimental Example 1 Analysis of Fatty Acid Composition
본 실험예에서는 오디 및 꾸지뽕 열매 씨앗 오일의 지방산(FA) 조성을 종래의 방법에 따라 가스 크로마토그래피(GC)로 측정하였다. GC 조건은 다음과 같다: SupelcowaxTM-10 융합-실리카 모세관 컬럼(60 m X 0.25 mm I.d.), FID 검출기, 담체 가스(He, 52.5 mL/min), 주입기(250℃), 오븐(190℃), 검출기(260℃), 온도계.In the present experimental example, the fatty acid (FA) composition of Audi and Cudrania seed oil was measured by gas chromatography (GC) according to a conventional method. GC conditions were as follows: SupelcowaxTM-10 fusion-silica capillary column (60 m × 0.25 mm Id), FID detector, carrier gas (He, 52.5 mL / min), injector (250 ° C.), oven (190 ° C.), Detector (260 ° C.), thermometer.
오디 및 꾸지뽕 열매 씨앗 오일의 지방산 조성을 하기 표 2에 나타내었다. The fatty acid composition of the Audi and Cudrania seed oil are shown in Table 2 below.
1) 검출되지 않음
2) 총 포화지방산
3) 총 불포화지방산Each figure is the mean ± SD of three analyzes
1) not detected
2) total saturated fatty acid
3) Total unsaturated fatty acid
오디 씨앗 오일은 8.40% 팔미트산, 3.52% 스테아르산, 5.75% 올레산, 81.40% 리놀레산, 0.63% 리놀렌산 및 0.30% 아라키돈산으로 이루어졌다. 꾸지뽕 열매 씨앗 오일은 10.18% 팔미트산, 0.15% 팔미톨레산, 3.0% 스테아르산, 11.39% 올레산, 74.37% 리놀레산, 0.58% 리놀렌산 및 0.33% 아라키돈산으로 이루어졌다. 이로부터, 두 가지 뽕나무 열매 씨앗 오일 사이에서 지방산 조성이 약간 상이하였지만 유사한 오일 조성이 관찰되었다. 검출된 지방산 조성 중, 리놀레산이 주 지방산이었고, 이어서 팔미트산 및 올레산이었고, 다른 지방산, 예를 들어 스테아르산, 리놀렌산 및 아라키돈산이 소량의 오일 성분이었다. 또한, 총 포화지방산(SFA) 함량은 오디 씨앗 오일에서 12.22% 내지 꾸지뽕 열매 씨앗 오일에서 13.51% 범위였고, 총 불포화지방산(USFA) 함량은 꾸지뽕 열매 씨앗 오일에서 86.49% 내지 오디 씨앗 오일에서 87.78% 범위였다.
The Audi seed oil consisted of 8.40% palmitic acid, 3.52% stearic acid, 5.75% oleic acid, 81.40% linoleic acid, 0.63% linolenic acid and 0.30% arachidonic acid. Cudrania fruit seed oil consisted of 10.18% palmitic acid, 0.15% palmitoleic acid, 3.0% stearic acid, 11.39% oleic acid, 74.37% linoleic acid, 0.58% linolenic acid and 0.33% arachidonic acid. From this, a similar oil composition was observed although the fatty acid composition was slightly different between the two mulberry seed oils. Of the fatty acid compositions detected, linoleic acid was the main fatty acid, followed by palmitic acid and oleic acid, and other fatty acids such as stearic acid, linolenic acid and arachidonic acid were minor oil components. In addition, total saturated fatty acid (SFA) content ranged from 12.22% in Audi seed oil to 13.51% in Cudrania seed oil, and total unsaturated fatty acid (USFA) content ranged from 86.49% in Cudrania seed oil to 87.78% in Audi seed oil. It was.
실험예Experimental Example 2 : 토코페롤 분석 2: Tocopherol Analysis
본 실험예에서는 오디 및 꾸지뽕 열매 씨앗 오일 중 네 가지의 토코페롤 이성질체 정량화를 종래의 방법에 따라 수행하였다. HPLC 조건은 다음과 같다: LiChrosorb DIOL 컬럼(5μm, 3 X 100mm, Merck Co., Chrompack, Palo Alto, CA, USA); 295nm UV 검출기(Younglin Absorbance, Seoul, Korea); 유동상, n-헥산-아세트산(1000:1, v/v); 유속 0.5mL/min.In this experimental example, the quantification of four tocopherol isomers in the Audi and Cudrania fruit seed oils was performed according to a conventional method. HPLC conditions were as follows: LiChrosorb DIOL column (5 μm, 3 × 100 mm, Merck Co., Chrompack, Palo Alto, CA, USA); 295 nm UV detector (Younglin Absorbance, Seoul, Korea); Fluidized bed, n-hexane-acetic acid (1000: 1, v / v); Flow rate 0.5 mL / min.
오디 및 꾸지뽕 열매 씨앗의 세 가지 토코페롤 이성질체, α-, γ- 및 β-토코페롤의 함량을 하기 표 3에 나타내었다.The contents of the three tocopherol isomers, α-, γ-, and β-tocopherols of the Audi and Cudrania fruit seeds are shown in Table 3 below.
오디 씨앗 오일은 99.64mg%의 총 토코페롤 함량을 가졌으며, 이들 중 α-토코페롤은 6.23mg%, γ-토코페롤은 17.96mg% 및 β-토코페롤은 75.45mg%였다. 반면, 꾸지뽕 열매 씨앗 오일은 16.07mg%의 총 토코페롤 함량을 가졌으며, 이들 중 α-토코페롤은 4.45mg%, γ-토코페롤은 7.46mg% 및 β-토코페롤은 4.16mg%였다. 오디 씨앗의 세 가지 토코페롤 수준이 꾸지뽕 열매 씨앗과 비교하여 유의적으로 높았으며, 특히 오디 씨앗의 γ- 및 β-토코페롤 함량이 꾸지뽕 열매 씨앗에서 보다 약 2.4 및 18배 높았다. 이로부터 오디 씨앗이 천연항산화제인 비타민 E의 우수한 공급원이 될 수 있음이 밝혀졌다.
Audi seed oil had a total tocopherol content of 99.64 mg%, of which 6.23 mg% for α-tocopherol, 17.96 mg% for γ-tocopherol and 75.45 mg% for β-tocopherol. On the other hand, the Cudrania fruit seed oil had a total tocopherol content of 16.07 mg%, of which 4.45 mg% of α-tocopherol, 7.46 mg% of γ-tocopherol and 4.16 mg% of β-tocopherol. The three tocopherol levels of the OD seeds were significantly higher than the KUJIGDON fruit seeds, in particular the γ- and β-tocopherol contents of the OD seeds were about 2.4 and 18 times higher than those of the KUJIDGE fruit seeds. It was found that Audi seeds could be an excellent source of vitamin E, a natural antioxidant.
실험예 3 : 피토스테롤 분석Experimental Example 3: Phytosterol Analysis
본 실험예에서는 오디 및 꾸지뽕 열매 씨앗 오일 중 세 가지의 피토스테롤 정량화를 종래의 방법에 따라 수행하였다. 씨앗 오일(0.1g)을 EtOH 중에서 2N KOH로 비누화시킨 후, GC에 주입하였다. GC의 조건은 다음과 같다: 울트라 2 융합-실리카 모세관 컬럼(60m X 0.25mm I.d.), FID 검출기, 담체 가스(He, 52.5mL/min), 주입기(300℃), 오븐(285℃), 검출기(300℃), 온도계. In this experimental example, three phytosterol quantifications of the Audi and Cudrania fruit seed oils were performed according to a conventional method. Seed oil (0.1 g) was saponified with 2N KOH in EtOH and then injected into GC. Conditions for GC are as follows: Ultra 2 fusion-silica capillary column (60m X 0.25mm Id), FID detector, carrier gas (He, 52.5mL / min), injector (300 ° C), oven (285 ° C), detector (300 ℃), thermometer.
오디 및 꾸지뽕 열매 씨앗의 피토스테롤 함량은 표 4에 나타내었다. Phytosterol content of the Audi and Cudrania fruit seeds are shown in Table 4.
세 가지 피토스테롤 유도체, 캄페스테롤, 스티그마스테롤 및 β-시토스테롤이 발견되었으며, 이들 중 β-시토스테롤이 주 성분이었다. 오디 씨앗 오일은 캄페스테롤 34.64mg%, 스티그마스테롤 10.29mg% 및 β-시토스테롤 460.66mg%로서, 총 피토스테롤 함량이 507. 59mg%였다. 꾸지뽕 열매 씨앗 오일은 캄페스테롤 24.54mg%, 스티그마스테롤 16.47mg% 및 β-시토스테롤 410.94mg%로서, 총 피토스테롤 함량이 451. 95mg%였다. 이로부터, 오디 씨앗의 총 피토스테롤 수준이 꾸지뽕 열매 씨앗 보다 높음을 알 수 있었고, 특히 오디 씨앗의 스티그마스테롤 함량이 꾸지뽕 열매 씨앗 보다 낮음에도 불구하고 오디 씨앗의 두 가지 피토스테롤인 캄페스테롤과 β-시토스테롤 함량이 꾸지뽕 열매 씨앗 보다 높았다.
Three phytosterol derivatives, campestrol, stigmasterol and β-sitosterol were found, of which β-sitosterol was the main component. Audi seed oils were 34.64 mg% camphorsterol, 10.29 mg% stigmasterol and 460.66 mg% β-sitosterol, with a total phytosterol content of 507.59 mg%. Cudrania fruit seed oil was 24.54 mg% camphorsterol, 16.47 mg% stigmasterol and 410.94 mg% β-sitosterol, with a total phytosterol content of 451.95 mg%. From these results, it was found that the total phytosterol level of the mulberry seeds was higher than that of the Cudrania fruit seeds. This was higher than the Cudrania fruit seeds.
실험예Experimental Example 4 : 총 폴리페놀 및 플라보노이드 함량 측정 4: Determination of total polyphenol and flavonoid content
본 실험예에서는 오디 및 꾸지뽕 열매 씨앗 MeOH 추출물의 총 폴리페놀 함량을 싱글턴 등의 종래 방법을 변형하여 폴린-시오칼테우 페놀 시약을 이용하여 측정하였다. 씨앗 추출물(1mL) 및 폴린-시오칼테우 시약(0.5mL)를 100mL 부피 플라스크에 넣었다. 3분 후, 20% Na2CO3 용액(2mL)을 가하고, 증류수로 채웠다. 1시간 후 UV-vis 분광광도계(Sinco, Seoul, Lorea)를 이용하여 760nm에서 흡광도를 측정하였다. 표준 검정 곡선에서 총 폴리페놀 함량을 갈산(gallic acid) 당량(mg/씨앗 100g)으로 나타내었다. In the present experimental example, the total polyphenol content of the mulberry extract and the zigzag fruit seed MeOH extract were measured by using a Pauline-Siocalceu phenol reagent by modifying a conventional method such as Singleton. Seed extract (1 mL) and Pauline-Siocalteu reagent (0.5 mL) were placed in a 100 mL volumetric flask. After 3 minutes, 20% Na 2 CO 3 solution (2 mL) was added and filled with distilled water. After 1 hour, the absorbance was measured at 760 nm using a UV-vis spectrophotometer (Sinco, Seoul, Lorea). The total polyphenol content is expressed in gallic acid equivalents (mg / seed 100 g) in a standard calibration curve.
플라보노이드 함량을 김 등의 비색 시험법을 변형하여 측정하였다. 시료 용액(0.5mL)을 10% 질산 알루미늄 비수화물 0.1mL, 1.0M 아세트산 칼륨 0.1mL 및 80% MeOH 4.3mL와 혼합한 후, 격렬히 볼텍싱하였다. 실온에서 40분 동안 배양한 후, 반응 혼합물의 흡광도를 415nm에서 측정하였다. 블랭크 군으로서 등량의 증류수로 10% 질산 알루미늄을 대체하였다. 표준 검정 곡선에서 총 플라보노이드 함량을 루틴 당량(mg/씨앗 100g)으로 나타내었다. Flavonoids content was determined by modifying the colorimetric assay, such as laver. The sample solution (0.5 mL) was mixed with 0.1 mL of 10% aluminum nitrate nonhydrate, 0.1 mL of 1.0 M potassium acetate, and 4.3 mL of 80% MeOH, followed by vigorous vortexing. After incubation at room temperature for 40 minutes, the absorbance of the reaction mixture was measured at 415 nm. As a blank group, 10% aluminum nitrate was replaced with an equal amount of distilled water. The total flavonoid content in the standard assay curve is expressed as rutin equivalent (mg / seed 100 g).
오디 및 꾸지뽕 열매 씨앗 잔사 중 폴리페놀 및 플라보노이드 함량을 하기 표 5에 나타내었다.The polyphenols and flavonoids content of the Audi and Cudrania fruit seed residues are shown in Table 5 below.
(mg/100g, dry base)Total polyphenols
(mg / 100g, dry base)
(mg/100g, dry base)Total polarvonoids
(mg / 100g, dry base)
오디 및 꾸지뽕 열매 씨앗 MeOH 추출물의 총 폴리페놀 함량은 각각 367.26 및 500.09mg%이었고, 총 플라보노이드 함량은 각각 106.52 및 74.26mg%였다. 따라서 총 폴리페놀 함량은 오디 씨앗의 경우가 꾸지뽕 열매 씨앗의 경우 보다 높았고, 총 플라보노이드 함량은 꾸지뽕 열매 씨앗의 경우가 오디 씨앗의 경우 보다 높았다. 오디 씨앗 MeOH 추출물의 총 페놀 함량이 꾸지뽕 열매 씨앗에서 보다 낮았음에도 보다 높은 총 플라보노이드 함량을 갖고 있음에 주목해 볼 필요가 있다.
The total polyphenol contents of the mulberry and Cudrania seed MeOH extracts were 367.26 and 500.09 mg%, respectively, and the total flavonoid contents were 106.52 and 74.26 mg%, respectively. Therefore, the total polyphenol content was higher in the case of odyssey seeds than in the case of Cudrania fruit seeds, and the total flavonoid content was higher in the case of Cudrania fruit seeds. It should be noted that although the total phenolic content of the mulberry seed MeOH extract was lower than that of the Cudrania fruit seeds, it had a higher total flavonoid content.
실험예 5 : MeOH 추출물의 생리활성 분석Experimental Example 5 Analysis of Biological Activity of MeOH Extract
본 실험예에서는 오디 및 꾸지뽕 열매 씨앗 MeOH 추출물의 항산화, 항당뇨 및 항노화 활성을 in vitro 분석 시스템에서 DPPH 라디칼, α-글루코시다제 및 트로시나제를 이용하여 각각 측정하였다.
In the present experimental example, the antioxidant, antidiabetic and anti-aging activities of the mulberry seedlings and the zigzag fruit seed MeOH extract were measured using DPPH radical, α-glucosidase and trocinase, respectively, in an in vitro assay system.
실험예 5-1 : 항산화 활성 분석Experimental Example 5-1: Antioxidant Activity Assay
본 실험예에서는 오디 및 꾸지뽕 열매 씨앗 MeOH 추출물의 항산화 활성을 블로이스의 방법을 변형하여 DPPH 라디칼로 측정하였다. 다양한 농도(0.1 ~ 10mg/mL)를 갖는 시료의 MeOH 용액(200μL)을 DPPH의 0.1mM 메탄올 용액(4mL)에 가하고, 격렬하게 진탕시켰다. 반응 혼합물을 실온에서 10분 동안 정치시키고, 517nm에서 흡광도를 측정하였다. 라디칼 소거 활성을 시료에 의한 자유 라디칼의 저해율(%)로 나타내고, 하기 식을 이용하여 계산하였다:In the present experimental example, the antioxidant activity of the mulberry seedlings and the kkujippong fruit seed MeOH extract was measured by the DPPH radical by modifying the method of Blyze. MeOH solution (200 μL) of samples with varying concentrations (0.1-10 mg / mL) was added to 0.1 mM methanol solution (4 mL) of DPPH and shaken vigorously. The reaction mixture was allowed to stand at room temperature for 10 minutes and the absorbance was measured at 517 nm. Radical scavenging activity is expressed as percent inhibition of free radicals by the sample and was calculated using the following formula:
DPPH 라디칼 소거 활성(%) = (대조군 OD - 시료 OD / 대조군 OD) × 100
DPPH radical scavenging activity (%) = (control OD-sample OD / control OD) × 100
실험예 5-2 : 항당뇨 활성 분석Experimental Example 5-2: Antidiabetic Activity Analysis
본 실험예에서는 오디 및 꾸지뽕 열매 씨앗 MeOH 추출물의 항당뇨 활성을 램 등의 방법을 변형하여 α-글루코시다제를 이용하여 측정하였다. 시료 용액[50μL, MeOH 중 0.01~1.0%(최종 농도 5%)]를 시험 튜브의 α-글루코시다제(0.15unit/mL)(50μL)에 가하였다. 반응 혼합물을 25℃에서 10분 동안 정치시킨 후, 인산염 완충액(pH 6.8) 중의 3mM의 p-니트로페닐-α-D-글루코피라노사이드(pNPG, 100μL)를 가하여 반응을 개시하였다. 반응을 37℃에서 15분 동안 수행한 후, 0.1M Na2CO3(750μL)를 가하여 반응을 중단시켰다. α-글루코시다제 저해 활성을 405nm에서 pNPG로부터 p-니트로페놀의 방출율을 측정하여 평가하였다.
In the present experimental example, the anti-diabetic activity of the mulberry seedlings MeOH extract was measured by using the α-glucosidase by modifying the method such as lamb. Sample solution [50 μL, 0.01-1.0% in MeOH (5% final concentration)] was added to α-glucosidase (0.15 unit / mL) (50 μL) in the test tube. The reaction mixture was allowed to stand at 25 ° C. for 10 minutes, then 3 mM p-nitrophenyl-α-D-glucopyranoside (pNPG, 100 μL) in phosphate buffer (pH 6.8) was added to initiate the reaction. After the reaction was performed at 37 ° C. for 15 minutes, the reaction was stopped by addition of 0.1 M Na 2 CO 3 (750 μL). α-glucosidase inhibitory activity was evaluated by measuring the release rate of p-nitrophenol from pNPG at 405 nm.
실험예 5-3 : 항노화 활성 측정Experimental Example 5-3: Anti-aging Activity Measurement
본 실험예에서는 오디 및 꾸지뽕 열매 씨앗 MeOH 추출물의 항노화 활성을 기질로서 L-DOPA를 이용한 최 등의 방법에 따라 머쉬룸 티로시나제를 이용하여 측정하였다. 1.5mM L-DOPA 용액 1mL, 시료를 포함한(또는 포함하지 않은) DMSO 0.1mL 및 1/15M 인산염 완충 용액(pH6.8)를 함유하는 기질로서 L-DOPA를 이용한 반응 혼합물(3mL)을 25℃에서 10분 동안 배양하였다. 수용액 중의 머쉬룸 티로시나아제 0.1mL를 추가로 혼합물에 가하여 475nm에서 광학 밀도의 선형 증가 초기 비율을 즉시 측정하였다. 대조 반응을 DMSO로 수행하였다. 티로시나아제 저해율(%)를 하기 식으로 계산하였다:In the present experimental example, the anti-aging activity of the mulberry seedlings MeOH extract was measured using mushroom tyrosinase according to the method such as L-DOPA as a substrate. The reaction mixture (3 mL) using L-DOPA as a substrate containing 1 mL of 1.5 mM L-DOPA solution, 0.1 mL of sample containing (or without) DMSO and 1 / 15M phosphate buffer solution (pH6.8) was 25 ° C. Incubated for 10 minutes at. 0.1 mL of mushroom tyrosinase in aqueous solution was further added to the mixture to immediately determine the initial linear increase in optical density at 475 nm. Control reactions were performed with DMSO. The percent tyrosinase inhibition was calculated by the following formula:
저해율(%) = (A-B)/A X 100% Inhibition = (A-B) / A X 100
상기 식에서, A는 시험 용액의 흡수능이고, B는 대조 용액의 흡수능이다.
Wherein A is the absorbency of the test solution and B is the absorbency of the control solution.
상기 실시예 5-1 내지 5-3의 결과를 하기 표 6으로 나타내었다. The results of Examples 5-1 to 5-3 are shown in Table 6 below.
1) 라디칼 소거 활성Each figure is the mean ± SD of three analyzes
1) radical scavenging activity
상기 표 6에 나타낸 바와 같이, 오디 및 꾸지뽕 열매 씨앗 MeOH 추출물은 용량 의존적 방식으로 높은 라디칼 소거 활성과 저해 활성을 나타내었으며, 각 추출물의 50% 저해 농도(IC50)를 상기 결과로부터 계산하였다. 오디 씨앗이 꾸지뽕 열매 씨앗에 비해 DPPH 라디칼(IC50=0.15mg/mL), α-글루코시다제(IC50=0.87mg/mL) 및 티로시나제(IC50=1.01mg/mL)에 대해 보다 높은 소거 활성 및 저해 활성을 나타내었다. 이러한 결과는 오디 씨앗 MeOH 추출물이 당뇨병 및 지질 과산화에 의한 피부노화를 방지하는 역할을 하며, 상기 표 5에 나타낸 바와 같은 항산화성 폴리페놀 화합물을 함유하고 있음을 나타내는 것이다.
As shown in Table 6, the mulberry extract and mulberry seed MeOH extract showed a high radical scavenging activity and inhibitory activity in a dose-dependent manner, 50% inhibition concentration (IC 50 ) of each extract was calculated from the results. Odysed seeds had higher clearance for DPPH radicals (IC 50 = 0.15 mg / mL), α-glucosidase (IC 50 = 0.87 mg / mL) and tyrosinase (IC 50 = 1.01 mg / mL) compared to Kudjippon fruit seeds Activity and inhibitory activity. These results indicate that the Audi seed MeOH extract serves to prevent skin aging due to diabetes and lipid peroxidation, and contains an antioxidant polyphenol compound as shown in Table 5 above.
실험예Experimental Example 6 : 폴리페놀 화합물의 정량 6: Quantitative determination of polyphenolic compounds
본 실험예에서는 오디 및 꾸지뽕 열매에서 얻은 탈지한 씨앗 잔사(10g)를 초음파분쇄기에서 80% EtOH 수용액(200mL)로 2회 추출하고, 여과하여 감압 하에서 용매를 증발시켰다. EtOH 추출물을 재차 80% EtOH 수용액 100mL에 용해시키고, 밤새 정치시켰다. 상기 용액을 5,000rpm에서 20분 동안 원심분리하고, 상층을 동일한 용매 100mL에 채웠다. 가용성 추출물(2mL)을 2회 희석하고, 0.45μm 멤브레인 필터(Gelman, USA)를 통과시킨 후, 폴리페놀 화합물 정량을 위해 HPLC 시스템에 주입하였다. HPLC는 2998 포토다이오드 어레이 검출기와 10μL 루프의 SM7 오토샘플러를 구비한 Waters e2690/5 HPLC 시스템 상에서 수행하였다. HPLC 분석은 Guard-Pak C18 프리컬럼 인서트를 갖춘 YMC-Pack Pro C18 컬럼(46mm I.d. X 250mm, YMC Inc., USA)를 사용하여 수행하였다. H2O 중 0.05% v/v H3PO4(용매 A) 내지 MeOH-CH3CN-H2O(1:1:1, v/v, 용매 B)의 선형 구배를 이용하여 60분 동안 0.8mL/min 유속에서 250, 310 및 350nm에서 검출함으로써 분리를 수행하였다. 용리 프로파일은 다음과 같다: 0~5분, 70% A, 30% B: 10~20분, 50% A, 50% B; 30~40분, 30% A, 70% B; 45~50분, 0% A, 100% B; 55~60분, 70% A, 30% B. 다음 주입 전에 상기 컬럼을 10분 동안 초기 조건으로 환원시켰다. 개개 폴리페놀 화합물의 그 정체 시간과 종래 보고에서 두 가지 뽕나무 열매에서 분리된 세 개의 표준 폴리페놀 화합물(레스베라트롤, 쿼세틴 및 4-프레릴모라신)의 정체시간을 비교하여 동정하였다. 종래 분리된 고유 시료로 공-크로마토그래피로 피크를 동정하였다. 각 폴리페놀 화합물에 대한 선형 상관관계 계수는 0.999 보다 컸다. 폴리페놀 화합물의 농도는 세 가지 표준 폴리페놀 화합물의 보정 곡선으로 측정하고, 건조 중량의 mg%로 나타내었다. 레스베라트롤, 4-프레닐모라신 및 쿼세틴의 회수율은 각각 97%, 98% 및 91%였다.
In the present experimental example, the degreased seed residue (10 g) obtained from the mulberry fruit and mulberry fruit was extracted twice with an 80% EtOH aqueous solution (200 mL) in an ultrasonic grinder, filtered and the solvent was evaporated under reduced pressure. The EtOH extract was again dissolved in 100 mL of an 80% aqueous solution of EtOH and left overnight. The solution was centrifuged at 5,000 rpm for 20 minutes and the top layer was charged with 100 mL of the same solvent. Soluble extract (2 mL) was diluted twice, passed through a 0.45 μm membrane filter (Gelman, USA) and then injected into an HPLC system for polyphenol compound quantification. HPLC was performed on a Waters e2690 / 5 HPLC system with a 2998 photodiode array detector and a SM7 autosampler in a 10 μL loop. HPLC analysis was performed using a YMC-Pack Pro C 18 column (46 mm Id × 250 mm, YMC Inc., USA) with Guard-Pak C18 precolumn inserts. H 2 O of 0.05% v / v H 3 PO 4 ( solvent A) to MeOH-CH 3 CN-H 2 O using a linear gradient of (1:: 1 1, v / v, solvent B) for 60 min. Separation was performed by detecting at 250, 310 and 350 nm at 0.8 mL / min flow rate. Elution profiles are as follows: 0-5 min, 70% A, 30% B: 10-20 min, 50% A, 50% B; 30-40 minutes, 30% A, 70% B; 45-50 minutes, 0% A, 100% B; 55-60 minutes, 70% A, 30% B. The column was reduced to initial conditions for 10 minutes before the next injection. The retention times of the individual polyphenol compounds were compared by comparison with the retention times of three standard polyphenol compounds (resveratrol, quercetin and 4-prerylmoracin) isolated from the two mulberry fruits in the previous report. Peaks were identified by co-chromatography with conventionally isolated native samples. The linear correlation coefficient for each polyphenol compound was greater than 0.999. The concentration of the polyphenolic compound was determined by the calibration curve of the three standard polyphenolic compounds and expressed in mg% of dry weight. The recovery of resveratrol, 4-prenylmoracin and quercetin was 97%, 98% and 91%, respectively.
도 1에 표준 폴리페놀 화합물(A)와 오디 씨앗 잔사의 MeOH 추출물(B)의 HPLC 크로마토그램을 도시하였다. 세 가지 주요 폴리페놀 화합물, 예를 들어, 레스베라트롤, 쿼세틴 및 4-프레릴모라신이 오디 씨앗 잔사의 MeOH 추출물에서 발견되었고, 이들의 함량은 각각 씨앗 잔사 100g 당 9.62, 54.83 및 48.70mg이었다. 이러한 결과는 상기 세 가지 폴리페놀 화합물이 오디 씨앗 잔사의 강력한 항산화, 항당뇨 및 항노화 활성의 원인이 된다는 사실을 보여주는 것이다. 1 shows the HPLC chromatogram of the standard polyphenol compound (A) and the MeOH extract (B) of the Audi seed residue. Three major polyphenol compounds, for example resveratrol, quercetin and 4-prerylmoracin, were found in the MeOH extract of the Audi seed residue, their contents being 9.62, 54.83 and 48.70 mg per 100 g of seed residue, respectively. These results show that the three polyphenolic compounds contribute to the strong antioxidant, antidiabetic and anti-aging activity of the mulberry seed residue.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020100093405A KR20120031800A (en) | 2010-09-27 | 2010-09-27 | An antioxidant, antidiabetic and antiaging composition containing mulberry fruit seed extracts |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020100093405A KR20120031800A (en) | 2010-09-27 | 2010-09-27 | An antioxidant, antidiabetic and antiaging composition containing mulberry fruit seed extracts |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20120031800A true KR20120031800A (en) | 2012-04-04 |
Family
ID=46135160
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020100093405A KR20120031800A (en) | 2010-09-27 | 2010-09-27 | An antioxidant, antidiabetic and antiaging composition containing mulberry fruit seed extracts |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20120031800A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014204853A1 (en) * | 2013-06-19 | 2014-12-24 | Access Business Group International Llc | Plant-based inhibitors of ketohexokinase for the support of weight management |
WO2015137633A1 (en) * | 2014-03-11 | 2015-09-17 | 주식회사 제이크린베리너리 | Composite extract of black raspberry oil, raspberry oil and mulberry oil |
KR20190074788A (en) * | 2017-12-20 | 2019-06-28 | 경남과학기술대학교 산학협력단 | A composition for anti-bacterial, skin-improving or anti-allergic activity containing extracts of Cudrania tricuspidata seed |
-
2010
- 2010-09-27 KR KR1020100093405A patent/KR20120031800A/en not_active Application Discontinuation
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014204853A1 (en) * | 2013-06-19 | 2014-12-24 | Access Business Group International Llc | Plant-based inhibitors of ketohexokinase for the support of weight management |
WO2015137633A1 (en) * | 2014-03-11 | 2015-09-17 | 주식회사 제이크린베리너리 | Composite extract of black raspberry oil, raspberry oil and mulberry oil |
KR20190074788A (en) * | 2017-12-20 | 2019-06-28 | 경남과학기술대학교 산학협력단 | A composition for anti-bacterial, skin-improving or anti-allergic activity containing extracts of Cudrania tricuspidata seed |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ferreira et al. | Citrus reticulata Blanco peels as a source of antioxidant and anti-proliferative phenolic compounds | |
Benayad et al. | Phenolic composition, antioxidant and anti-inflammatory activities of extracts from Moroccan Opuntia ficus-indica flowers obtained by different extraction methods | |
Zhao et al. | Bioactive substances of plant origin 30 | |
Wang et al. | Chemical constituents with antioxidant activities from litchi (Litchi chinensis Sonn.) seeds | |
Seeram et al. | Pomegranate phytochemicals | |
Stevanovic et al. | Bioactive polyphenols from healthy diets and forest biomass | |
WO2012055010A1 (en) | Maple tree-derived products and uses thereof | |
Nguyen et al. | Screening of ${\alpha} $-Glucosidase Inhibitory Activity of Vietnamese Medicinal Plants: Isolation of Active Principles from Oroxylum indicum | |
KR20090084439A (en) | A composition comprising extract of sophora flavescens or prenylated flavonoids compounds isolated therefrom preventing or treating diabetic complication | |
CN101006095A (en) | Lipase inhibitor | |
Ren-Geng et al. | Non-volatile constituents and pharmacology of Chimonanthus: A review | |
Klomsakul et al. | Evaluation of antioxidant activities and tyrosinase inhibitory effects of Ginkgo biloba tea extract | |
Nugroho et al. | Isolation and quantitative analysis of peroxynitrite scavengers from Artemisia princeps var. orientalis | |
KR20120031800A (en) | An antioxidant, antidiabetic and antiaging composition containing mulberry fruit seed extracts | |
KR100514916B1 (en) | Composition comprising the extract and flavonoid compounds isolated from Nelumbo nucifera stamen having antioxidation activity | |
KR101623209B1 (en) | Composition comprising isolated from Cassia tora or Cassia obtusifolia or for the prevention and treatment of cognitive dysfunction disorder | |
KR101373653B1 (en) | A composition comprising the extract of Rosa rugosa for preventing and treating benign prostatic hyperplasia | |
KR20090072858A (en) | Composition comprising the compound isolated from fraxinus rhynchophylla hance for preventing and treating brain disease | |
KR20220046810A (en) | Composition for preventing or treating respiratory function damage caused by fine dust using citrus fruits peel and method for preparing the same | |
Kim et al. | Comparison of functional constituents and biological activity of the seed extracts from two mulberry fruits | |
KR101059075B1 (en) | Composition for the treatment and prevention of alcoholic liver disease containing non-leaflet extract | |
KR100845339B1 (en) | Composition comprising an extract of leonurus heterophyllus sweet. for preventing and treating arteriosclerosis | |
KR102341031B1 (en) | Composition for protecting and treating cardiovascular disease comprising Boesenbergia rotunda | |
Lemoine et al. | A Characterization of Biological Activities and Bioactive Phenolics from the Non-Volatile Fraction of the Edible and Medicinal Halophyte Sea Fennel (Crithmum maritimum L.) | |
KR100637263B1 (en) | A pharmaceutical composition comprising the extract of Sorbus amurensis KOEHNE for treating or preventing cerebrovascular system disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E601 | Decision to refuse application |